Skip to content
Clinical Trials – home

Uniwersyteckie Centrum Kliniczne

Verifiedinfo

Poland Ul. Mariana Smoluchowskiego 17, 80-214 Gdansk, Poland

  • 218 trials recruiting
  • Non-small cell lung cancer · Acute myeloid leukaemia · Plasma cell myeloma
  • Adults and children

About Specializations

Uniwersyteckie Centrum Kliniczne in Gdansk, Poland specialises in clinical trials of conditions such as Non-small cell lung cancer, Acute myeloid leukaemia, Plasma cell myeloma, Non-small cell lung cancer stage IV, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

At Uniwersyteckie Centrum Kliniczne in Gdansk, research in immune system diseases focuses on conditions such as myasthenia gravis and the prevention of Herpes Zoster in immunocompromised children and adolescents. These studies are designed to better understand treatment response, immune protection, and overall safety in younger patients.

  • Evaluating new treatment options for generalized myasthenia gravis in children and adolescents
  • Studying pediatric Herpes Zoster prevention in immunocompromised patients
  • Assessing immune response and safety in pediatric populations

This area of research supports improved care for children with complex immune-related conditions, with a strong emphasis on therapy effectiveness and protection against infection.

Nervous System Diseases

Clinical trials in nervous system diseases at this site examine relapsing-remitting multiple sclerosis and spinal muscular atrophy, with the goal of improving treatment outcomes for pediatric patients. The work includes efforts to evaluate how well therapies are tolerated and how they affect disease control and functional development.

  • Investigating treatment effects in relapsing-remitting multiple sclerosis
  • Exploring therapy response in spinal muscular atrophy
  • Supporting better disease management in children and adolescents

The research reflects a broad commitment to advancing care in pediatric neurology, especially for conditions that can significantly affect movement, strength, and long-term neurological health.

Musculoskeletal Diseases

Studies in musculoskeletal diseases at Uniwersyteckie Centrum Kliniczne are closely linked to disorders that affect muscle function and physical ability, particularly spinal muscular atrophy and myasthenia gravis. These trials aim to determine whether emerging therapies can improve strength, mobility, and everyday functioning in young patients.

  • Examining therapies for muscle weakness and impaired movement
  • Focusing on functional improvement in spinal muscular atrophy
  • Assessing treatment benefit in myasthenia gravis

This research area helps clarify how new approaches may support better physical outcomes and quality of life for children living with neuromuscular conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Mariana Smoluchowskiego 1780-214 GdanskPoland
Recruiting now
218 trials
Conditions studied
207
Partner status
Verified

More sites in GdanskPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

567 clinical trials

Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:BioNTech SE
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ruxolitinib
  • Sponsor:Ryvu Therapeutics S.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.